Data gathered: February 23
AI Stock Analysis - Amgen (AMGN)
Analysis generated November 26, 2024. Powered by Chat GPT.
Amgen Inc. is a leading biotechnology company that develops and manufactures human therapeutics. With a broad portfolio that includes treatments for cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses, Amgen is well-positioned in the biopharmaceutical sector. The company has a strong commitment to research and development, and it currently has multiple products in various stages of development. Amgen operates globally, with a presence in numerous countries, and is headquartered in Thousand Oaks, California.
Stock Alerts - Amgen (AMGN)
 |
Amgen | February 22 Insider Alert: REESE DAVID M is selling shares |
|
Amgen | February 21 Insider Alert: Miller Derek is selling shares |
|
Amgen | February 14 Insider Alert: Gordon Murdo is selling shares |
|
Amgen | February 12 Emily Randall (member of U.S. congress) is selling shares |
Alternative Data for Amgen
About Amgen
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
| Price | $303.01 |
| Target Price | Sign up |
| Volume | 3,260,000 |
| Market Cap | $163B |
| Year Range | $256.49 - $331.97 |
| Dividend Yield | 3.14% |
| PE Ratio | 40.19 |
| Analyst Rating | 53% buy |
| Industry | Biotechnology |
In the news
Amgen Inc. stock outperforms competitors on strong trading dayFebruary 21 - MarketWatch |
|
 |
Amgen, Inc. (AMGN) Citi's 2025 Virtual Oncology Leadership Summit Conference (Transcript)February 19 - SeekingAlpha |
 |
Short Interest in Amgen Inc. (NASDAQ:AMGN) Rises By 11.5%February 17 - ETF Daily News |
Amgen Inc. (AMGN): Among the Best Drug Stocks to Buy NowFebruary 16 - Yahoo Entertainment |
|
Amgen Inc. stock underperforms Friday when compared to competitorsFebruary 14 - MarketWatch |
|
|
Gladstone Institutional Advisory LLC Trims Stock Holdings in Amgen Inc. (NASDAQ:AMGN)February 14 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 8.5B | 6.14B | 2.37B | 2.83B | 5.08B | 5.580 |
| Q2 '24 | 8.52B | 6.22B | 2.3B | 746M | 2.8B | 4.970 |
| Q1 '24 | 6.76B | 6.21B | 548M | -113M | 1.96B | 3.960 |
| Q4 '23 | 7.63B | 6.5B | 1.13B | 767M | 2.77B | 4.710 |
| Q3 '23 | 6.33B | 3.88B | 2.44B | 1.73B | 3.4B | 4.960 |
Insider Transactions View All
| REESE DAVID M filed to sell 36,922 shares at $304.4. February 21 '25 |
| Miller Derek filed to sell 8,544 shares at $293.7. February 20 '25 |
| REESE DAVID M filed to sell 62,147 shares at $293.2. February 21 '25 |
| Santos Esteban filed to sell 71,546 shares at $292.8. February 21 '25 |
| Miller Derek filed to sell 8,544 shares at $292.6. February 20 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Emily Randall |
Feb 12, 25 | Sell | $1K - $15K |
| Virginia Foxx |
Jan 7, 25 | Buy | $1K - $15K |
| Ro Khanna |
Nov 11, 24 | Buy | $1K - $15K |
Read more about Amgen (AMGN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Amgen?
The Market Cap of Amgen is $163B.
What is Amgen's PE Ratio?
As of today, Amgen's PE (Price to Earnings) ratio is 40.19.
What is the current stock price of Amgen?
Currently, the price of one share of Amgen stock is $303.01.
How can I analyze the AMGN stock price chart for investment decisions?
The AMGN stock price chart above provides a comprehensive visual representation of Amgen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amgen shares. Our platform offers an up-to-date AMGN stock price chart, along with technical data analysis and alternative data insights.
Does AMGN offer dividends to its shareholders?
Yes, Amgen (AMGN) offers dividends to its shareholders, with a dividend yield of 3.14%. This dividend yield represents Amgen's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Amgen in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Amgen?
Some of the similar stocks of Amgen are Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Anavex Life Sciences, and BridgeBio Pharma.
.